Off-label uses of drugs for depression

被引:33
|
作者
Skanland, Sigrid S. [1 ,2 ,3 ]
Cieslar-Pobuda, Artur [1 ,3 ,4 ]
机构
[1] Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, Oslo, Norway
[2] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Inst Clin Med, Oslo, Norway
[3] Univ Oslo, KG Jebsen Ctr Canc Immunotherapy, Inst Clin Med, Oslo, Norway
[4] Univ Oslo, Ctr Mol Med Norway NCMM, Nordic EMBL Partnership, Oslo, Norway
关键词
Antidepressants; Chronic pain; Eating disorders; Off-label; Sleep disorders; Smoking cessation; MENOPAUSAL VASOMOTOR SYMPTOMS; PERIPHERAL NEUROPATHIC PAIN; SUSTAINED-RELEASE BUPROPION; HOT FLASHES; PHARMACOLOGICAL-TREATMENT; ANOREXIA-NERVOSA; PREMATURE EJACULATION; PSYCHIATRIC-DISORDERS; MIGRAINE PROPHYLAXIS; NICOTINE WITHDRAWAL;
D O I
10.1016/j.ejphar.2019.172732
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The prescription of drugs for depression is rising rapidly. One of the reasons for this trend is their many off-label uses. Up to one third of all prescriptions are for non-indicated use, which in addition to drug repurposing includes different dosing or duration than those recommended. In this review, we elaborate on what antidepressants can treat besides depression. The five classes of drugs for depression are introduced, and their mechanisms of action and serious side effects are described. The most common off-label uses of antidepressants are discussed, with a special focus on treating eating disorders, sleep problems, smoking cessation and managing chronic pain. Depression is often a comorbidity when antidepressants are chosen as therapy, but good therapeutic effects have been observed for other conditions also when depression is not involved. Finally, a new type of antidepressant developed from the hallucinogenic "party drug" ketamine is briefly introduced. This recent development suggests that antidepressants will keep playing a central role in medicine for years to come.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] OFF-LABEL USES OF ANTICANCER DRUGS
    ABELOFF, MD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (18): : 2473 - 2474
  • [2] Off-label uses of drugs in children
    Blumer, JL
    [J]. PEDIATRICS, 1999, 104 (03) : 598 - 602
  • [3] Common Drugs with Effective Off-Label Uses
    Alshehri, Mohammed M.
    Mudawi, Mahmoud M. E.
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (10)
  • [4] OFF-LABEL USES OF ANTICANCER DRUGS - REPLY
    MOERTEL, CG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (18): : 2474 - 2474
  • [5] Uses of drugs not described in the package insert (off-label uses)
    Ward, RM
    Bates, BA
    Benitz, WE
    Burchfield, DJ
    Ring, JC
    Walls, RP
    Walson, PD
    [J]. PEDIATRICS, 2002, 110 (01) : 181 - 183
  • [6] Products liability and ''off-label'' uses of prescription drugs
    Stoffelmayr, KJ
    [J]. UNIVERSITY OF CHICAGO LAW REVIEW, 1996, 63 (01): : 275 - 306
  • [7] CONSUMERS AT RISK - OFF-LABEL USES OF MEDICAL DRUGS AND DEVICES
    PAYNE, DM
    [J]. TRIAL, 1993, 29 (08): : 26 - 28
  • [8] Unlicensed and off-label uses of drugs in paediatrics: a review of the literature
    Cuzzolin, L
    Zaccaron, A
    Fanos, V
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (01) : 125 - 131
  • [9] DRUGS PRESCRIPTION PATTERN AND OFF-LABEL USES IN PALLIATIVE CARE
    Blanco-Reina, E.
    Herrera-Moreno, C.
    Garcia-Salcines, J. R.
    Bellido-Estevez, I.
    Marquez-Romero, E. I.
    Gomez-Huelgas, R.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 25 - 25
  • [10] OFF-LABEL USES OF DRUGS IN JAPANESE CHILDREN WITH KIDNEY DISEASES
    Yata, N.
    Ishikura, K.
    Honda, M.
    [J]. PEDIATRIC NEPHROLOGY, 2009, 24 (03) : 682 - 682